Bolt Biotherapeutics (BOLT) Misses Q3 EPS by 372c
Tweet
Share
E-mailGet Alerts BOLT Hot Sheet
Join SI Premium – FREE
Bolt Biotherapeutics (NASDAQ: BOLT) reported Q3 EPS of ($3.72). Revenue for the quarter came in at $2.17 million.
For earnings history and earnings-related data on Bolt Biotherapeutics (BOLT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
